Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Brown University
QuantumLeap Healthcare Collaborative
Eastern Cooperative Oncology Group
NKGen Biotech, Inc.
Washington University School of Medicine